More than a dozen top bankers moved to strategic and M&A roles in pharmaceutical companies, spearheading mergers and acquisition as well as fundraising plans. They included Nitin Tandon, who joined as head business development, Asia Pacific, at Johnson & Johnson from Credit Suisse.from Industry-Economic Times
Read The Rest:economictimes...
